Alternative splicing and biological heterogeneity in prostate cancer

Rajan, P., Elliott, D.J., Robson, C.N. and Leung, H.Y. (2009) Alternative splicing and biological heterogeneity in prostate cancer. Nature Reviews Urology, 6(8), pp. 454-460. (doi:10.1038/nrurol.2009.125)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1038/nrurol.2009.125

Abstract

The biological diversity of prostate cancer confounds standardization of therapy. Advances in molecular profiling suggest that differences in the genetic composition of tumors significantly contribute to the complexity of the disease. Alternative pre-mrNA splicing is a key genetic process underlying biological diversity. During alternative splicing, coding and noncoding regions of a single gene are rearranged to generate several messenger RNA transcripts yielding distinct protein isoforms with differing biological functions. Misregulation of the splicing machinery and mutations in key regulatory elements affect splicing of cancer-relevant genes. in prostate cancer, aberrant and alternative splicing generates proteins that influence cell phenotypes and survival of patients. splicing events may be exploited for clinical benefit, and technological advances are beginning to uncover novel biomarkers and therapeutic targets. since splicing mediates information transfer from the genome to the proteome, it adds an important dimension to '-omics'-based molecular signatures used to individualize care of patients.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Leung, Professor Hing and Rajan, Dr Prabhakar
Authors: Rajan, P., Elliott, D.J., Robson, C.N., and Leung, H.Y.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Nature Reviews Urology
ISSN:1759-4812

University Staff: Request a correction | Enlighten Editors: Update this record